Accuray Stock Hits New 52-Week Low (ARAY)

NEW YORK ( TheStreet) -- Accuray (Nasdaq: ARAY) hit a new 52-week low Tuesday as it is currently trading at $3.54, below its previous 52-week low of $3.55 with 259,641 shares traded as of 2:14 p.m. ET. Average volume has been 962,400 shares over the past 30 days.

Accuray has a market cap of $282 million and is part of the health care sector and health services industry. Shares are down 46.4% year to date as of the close of trading on Monday.

Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company offers the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors.
  • Practice your ARAY trading strategies and win cash in our stock game.

TheStreet Ratings rates Accuray as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself. You can view the full Accuray Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs